ScholarLens Back to search
2016•Annals of the Rheumatic DiseasesRequires access

OP0155 Development of A JAK3 Specific Inhibitor Clinical Candidate: Functional Differentiation of JAK3 Selective Inhibition over PAN-JAK or JAK1 Selective Inhibition

Jean‐Baptiste Telliez, L. Wang, Jason Jussif, Tsung H. Lin, L. Li, Erick Moy, W. Li, Yajuan Zhao, Kimberly Crouse, Peter T. Symanowicz, Martin Hegen, Mary Ellen Banker, Fabien Vincent, Jerry D. Clark, Atli Thorarensen

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Janus kinase 1, Tyrosine kinase 2, Janus kinase, Cytokine, Janus kinase 3, Cytokine receptor, Common gamma chain, Medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
OP0155 Development of A JAK3 Specific Inhibitor Clinical Candidate: Functional Differentiation of JAK3 Selective Inhibition over PAN-JAK or JAK1 Selective Inhibition — Research Paper | ScholarLens